Tag: New Hampshire

Manchester Teams with Treatment Providers for Renewed Effort to Respond to Addiction Epidemic

New Partnerships to Replace Serenity Place Programs; Safe Station to Continue for Manchester; Crisis Hotline Use Encouraged Statewide

Manchester, NH – Citing lessons learned from the closing of the non-profit substance use treatment center known as Serenity Place, Manchester Mayor Joyce Craig, emergency responders and a team of providers, including Families in Transition, the Farnum Center and Granite Pathways, have developed a new strategy for responding to the opioid crisis in New Hampshire. In an effort to preserve Safe Station as a critical entry point for care, the Mayor and providers have developed a new network to respond to those in need.


Node Investigators Launch Purple Pod to Augment Care for Pregnant Women on Buprenorphine

This past September, Dartmouth-Hitchcock Medical Center’s (DHMC; Lebanon, NH) Division of Obstetrics and Gynecology (OB/GYN) implemented the Purple Pod – a division of OB/GYN that provides weekly clinics for patients with pregnancies complicated by substance use disorders (SUDs) who are receiving medication-assisted treatment (MAT) from providers outside of the hospital’s “Moms in Recovery” program.


Catholic Medical Center hosts 3rd annual Summit on Treating Opiate-Dependent Patients

In November, our partner at Catholic Medical Center (CMC) hosted its third annual Summit on Treating Opiate-Dependent Patients. The annual Summit brings together physicians, dentists, podiatrists, nurse practitioners, physician assistants, other prescribers, nurses, social workers, allied health professionals, pharmacists, social service agencies, law enforcement, first responders and other stakeholders to discuss New Hampshire’s opioid epidemic.


Northeast Node to study Manchester’s Safe Station program


Photo courtesy the New Hampshire Union Leader.

New Hampshire is in the midst of an unprecedented opioid crisis. Recent CDC data from 2015 places the state second in the nation in opioid-related overdose fatalities and first in synthetic non-methadone opioid (fentanyl)-related overdose fatalities per capita. More New Hampshirites die every year from opioid overdoses than residents of every other state in the nation. The state also has one of the lowest treatment availability rates in the nation (for more on this and New Hampshire’s problem, see the Rapid HotSpot Phase I and Phase II studies the Node conducted). People who need help treating their opioid use disorders have limited resources available to them. To combat this problem in the state’s largest city, the Manchester Fire Department created Safe Station, a connection to recovery program that allows users to ask for help and get it immediately. No waiting lists, no multi-visit process, just access to treatment when people need and want it most.


HotSpot Phase II Initial Report Released

The Northeast Node, alongside partners at our parent institution from the Dartmouth Center for Technology and Behavioral Health (CTBH), have released the initial findings from our Phase II HotSpot study, Understanding Opioid Overdoses in New Hampshire.


Node welcomed NIDA Director, Congresswoman, Senator to discuss tackling NH’s opioid epidemic with science

On Tuesday, May 30, 2017, the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, together with the Center for Technology and Behavioral Health (CTBH) at the Geisel School of Medicine at Dartmouth, welcomed the Director of the National Institute on Drug Abuse (NIDA), Dr. Nora Volkow, and New Hampshire State Representative Ann McLane Kuster (D-NH2) to discuss New Hampshire’s Opioid Crisis.


NH launches Zero Left campaign to eliminate leftover prescription opioids

In response to the opioid crisis affecting the region, New Hampshire’s Granite Health announced the launch of the Zero Left campaign. The goal is to educate the public and provide services so that no “leftover” prescribed opioids end up in medicine cabinets where others can easily access them.


Northeast Node co-hosting NIDA Director, NH state rep at opioid crisis conference


A crabapple tree blooms with Baker Tower in the background.

Together with the Dartmouth Center for Technology and Behavioral Health at the Geisel School of Medicine at Dartmouth, the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network will co-host Dr. Nora Volkow, Director of the National Institute on Drug Abuse, and New Hampshire State Representative Ann McLane Kuster, at a conference focused on New Hampshire’s opioid crisis.


April DMI report: NH projecting a 9% increase in OD deaths over 2016

The New Hampshire Drug Monitoring Initiative (DMI) has released its April 2017 Drug Environment Report. As of April, New Hampshire is projected to see a 9% increase in overdose deaths over 2016.


Dr. Lisa Marsch testifies at House Bipartisan Heroin Task Force on NH fentanyl overdose crisis

On Monday, February 6, Dr. Lisa Marsch, Director of the Northeast Node and the Center for Technology and Behavioral Health (CTBH), testified at a Congressional briefing of the House Bipartisan Heroin Task Force.